01
Nov
High-dose Influenza Vaccine Study for People Ages 50-64
We are currently recruiting people ages 50 to 64 who have not yet received this season’s (2024-2025) influenza (flu) vaccine to participate in a clinical trial of an investigational flu vaccine. This Phase 3 trial, sponsored by Sanofi, will evaluate how well an investigational high-dose...
